Your browser doesn't support javascript.
loading
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database.
Stajszczyk, Marcin; Obarska, Izabela; Jeka, Slawomir; Batko, Bogdan.
Affiliation
  • Stajszczyk M; Department of Rheumatology and Autoimmune Diseases, Silesian Center for Rheumatology, Orthopedics and Rehabilitation, Ustron, Poland marcin.stajszczyk@mp.pl.
  • Obarska I; HealthCare System Navigator, Warszawa, Poland.
  • Jeka S; Clinical Department of Rheumatology and Connective Tissue Disease, Collegium Medicum UMK, University Hospital No. 2, Bydgoszcz, Poland.
  • Batko B; Department of Rheumatology and Immunology, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University, Kraków, Poland.
Ann Rheum Dis ; 82(9): 1171-1180, 2023 09.
Article in En | MEDLINE | ID: mdl-37328194
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / Antirheumatic Agents / Biosimilar Pharmaceuticals Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Rheum Dis Year: 2023 Document type: Article Affiliation country: Polonia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / Antirheumatic Agents / Biosimilar Pharmaceuticals Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Rheum Dis Year: 2023 Document type: Article Affiliation country: Polonia Country of publication: Reino Unido